What is Teladoc Health's convertible debentures?

Teladoc Health (TDOC) reported convertible debentures of $995.81M in Q1 2026.

How has Teladoc Health's convertible debentures changed year-over-year?

Teladoc Health's convertible debentures increased by 0.4% year-over-year, from $992.29M to $995.81M.

What is the long-term trend for Teladoc Health's convertible debentures?

Over 5 years (2020 to 2025), Teladoc Health's convertible debentures has grown at a -6.3% compound annual growth rate (CAGR), from $1.38B to $994.93M.

Teladoc Health TDOC Convertible debentures

Convertible debentures at other companies

Hims & Hers HealthHIMS

——

Other financials

Income statement

See full

Revenue$613.8M-2.5%

Gross profit$416.3M-3.8%

Operating income-$61.8M+48.8%

Net income-$63.8M+31.4%

EPS (diluted)-$0.36+32.1%

Balance sheet

See full

Cash & equivalents$750.7M-37.1%

Total debt$42.2M-92.9%

Total equity$1.3B-6.4%

Total assets$2.8B-18.5%

Cash flow

See full

Operating cash flow$9.5M-40.2%

CapEx$1.7M-39.1%

Free cash flow$7.9M-40.5%

Valuation

See full

Market cap$1.41B+16.5%

Enterprise value$701.31M+14.7%

P/S0.6×+0.1×

Profitability

See full

Gross margin69.3%-1.2pp

Operating margin-8.1%-3.6pp

Net margin-6.8%-3.1pp

FCF margin11.1%-0.2pp

Returns & leverage

See full

Return on equity-12.4%-5.4pp

Debt / equity0×-0.4×

Current ratio2.8×+1.1×

Where this comes from

Reported directly by Teladoc Health in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtNoncurrent.

The official record: Teladoc Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teladoc Health's convertible debentures.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Teladoc Health's convertible debentures?: Teladoc Health (TDOC) reported convertible debentures of $995.81M in Q1 2026.
How has Teladoc Health's convertible debentures changed year-over-year?: Teladoc Health's convertible debentures increased by 0.4% year-over-year, from $992.29M to $995.81M.
What is the long-term trend for Teladoc Health's convertible debentures?: Over 5 years (2020 to 2025), Teladoc Health's convertible debentures has grown at a -6.3% compound annual growth rate (CAGR), from $1.38B to $994.93M.